Extrinsic apoptotic pathways, anti-TNF-alpha therapy and cancer progression: more and more clinical data support this critical relationship?
Onkoderma- Policlinic for Dermatology and Dermatologic Surgery, General Skobelev 26, Sofia, Bulgaria.
Anastasiya Atanasova
AA
Chokoeva
Policlinic for Dermatology and Venereology, Medical Faculty, University Hospital Lozenetz, Saint Kliment Ohridski University, Sofia, Bulgaria.
Georgi
G
Tchernev
University of Rome "G. Marconi,", Rome.|Institute of Dermatology LifeCronos, Florence, Italy.
Torello
T
Lotti
Department of Dermatology and Allergology, Hospital Dresden-Friedrichstadt, Academic Teaching Hospital, Technical University of Dresden, Dresden, Germany.
Uwe
U
Wollina
D000068879:Adalimumab / Q000494:pharmacology*; D018501:Antirheumatic Agents / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects*; D015551:Autoimmunity / Q000187:drug effects; D063646:Carcinogenesis / Q000187:drug effects*; D000068800:Etanercept / Q000494:pharmacology*; D006801:Humans; D009375:Neoplasms, Glandular and Epithelial / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000068879:Adalimumab; D000068800:Etanercept